Abstract
Three patients, aged 10-18 yrs, with uncontrolled hypertension, have been treated with the angiotensin I converting enzyme inhibitor (captopril) for 15-29 mos. Their diagnoses are malignant hypertension of unknown etiology, Takayasu's arteritis with renal involvement and single kidney hydronephrosis and renal artery stenosis. Two patients had four test doses of oral captopril in doses of 12.5-50 mg. The changes in Mean Arterial Pressure (MAP) and Plasma Renin Activity (PRA) at 90′ were:
Serum aldosterone decreased by 90′ in all tests by an average of 81.2%, range 78.1-91.2%. The MAP in two patients on captopril alone, 150-250 mg/day, decreased by 6.4 and 18.8%. The third, with Takayasu's arteritis, is taking prazosin in addition to 400 mg of captopril. His MAP has decreased by 9.6% but he remains severely hypertensive. In all three PRA has remained elevated and serum and urinary aldosterone levels have remained suppressed. Retinal and cardiac hypertensive changes have improved. We conclude captopril can be a useful therapeutic modality in the treatment of uncontrolled childhood hypertension.
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rapaport, R., Levine, L., Starkman, H. et al. 439 ACUTE AND CHRONIC USE OF THE ANGIOTENSIN I CONVERTING ENZYME INHIBITOR (CAPTOPRIL) IN CHILDHOOD HYPERTENSION. Pediatr Res 15 (Suppl 4), 513 (1981). https://doi.org/10.1203/00006450-198104001-00450
Issue Date:
DOI: https://doi.org/10.1203/00006450-198104001-00450